Quick Answer
WEST PHARMACEUTICAL SERVICES INC reported Revenue (ASC 606) of $3.07 billion for fiscal year 2025.
WEST PHARMACEUTICAL SERVICES INC Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $3.07B | +6.3% |
| 2024 | $2.89B | -1.9% |
| 2023 | $2.95B | +2.2% |
| 2022 | $2.89B | +2.0% |
| 2021 | $2.83B | +31.9% |
| 2020 | $2.15B | +16.7% |
| 2019 | $1.84B | +7.1% |
| 2018 | $1.72B | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $804.60M | +7.7% | +5.0% |
| June 30, 2025 | $766.50M | +9.2% | +9.8% |
| March 31, 2025 | $698.00M | +0.4% | -6.5% |
| September 30, 2024 | $746.90M | -0.1% | +6.4% |
| June 30, 2024 | $702.10M | -6.9% | +1.0% |
| March 31, 2024 | $695.40M | -3.0% | -7.0% |
| September 30, 2023 | $747.40M | +8.8% | -0.8% |
| June 30, 2023 | $753.80M | -2.3% | +5.2% |
- WEST PHARMACEUTICAL SERVICES INC showed an increase of +6.3% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2018–2025 period, WEST PHARMACEUTICAL SERVICES INC’s revenue (asc 606) has grown by 79.0% (from $1.72 billion to $3.07 billion).
- The most recent figure is from WEST PHARMACEUTICAL SERVICES INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: